[column lg=”4″ md=”12″ sm=”12″ xs=”12″ ]
[column lg=”8″ md=”12″ sm=”12″ xs=”12″ ]
Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London
Higher Brain Functions
Title of the talk:
The Psychedelic Research Group at Imperial focuses on two main research areas: 1) the action of psychedelic drugs in the brain, and 2) their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression. The group is lead by Dr Robin Carhart-Harris with oversight from Professor David Nutt. Robin Carhart-Harris has studied effects of LSD, psilocybin (magic mushrooms), and MDMA on the brain, conducting some of the first brain imaging studies of these drugs. Most recently he has been running a clinical trial looking at the potential of psilocybin to treat depression.
[button style=”btn-danger btn-sm” icon=”glyphicon glyphicon-chevron-right” align=”right” type=”link” target=”false” title=”More speakers” link=”https://www.neurizons.uni-goettingen.de/programme/speakers-2018/”]